8.94 USD
▲+0.15+6.05%
盘后 8.36 -0.83%
2026-08-03
市值
$194.66M
市盈率
—
EPS
-1.37
股息率
—
52 周区间
4.50 – 10.10
成交量
48.93K
Beta
2.23
目标价
16.00
52W 低 4.5052W 高 10.10
价格走势
公司简介
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company’s commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer’s disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impa...